Mergers & Acquisitions Mergers & Acquisitions

UnitedHealthcare unlikely to share innovation on 'equal footing' after acquiring Change Healthcare, DOJ expert testifies

By Khushita Vasant
  • 10 Aug 2022 01:28
  • 10 Aug 2022 01:28
UnitedHealthcare Group’s $13 billion proposed acquisition of Change Healthcare will not reduce innovation in the healthcare claims industry, but it is likely to hurt competition because UnitedHealth is unlikely to share innovations with rivals on an “equal footing,” an expert witness for the US Department of Justice said today.

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US

Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News